Atherosclerotic renovascular disease among hypertensive adults Ross P. Davis, MD, Jeffrey D. Pearce, MD, Timothy E. Craven, MSPH, Phillip S. Moore, MD, Matthew S. Edwards, MD, Christopher J. Godshall, MD, Kimberley J. Hansen, MD Journal of Vascular Surgery Volume 50, Issue 3, Pages 564-571.e3 (September 2009) DOI: 10.1016/j.jvs.2009.03.062 Copyright © 2009 Society for Vascular Surgery Terms and Conditions
Fig 1 Estimated rates of peak systolic velocity (PSV) progression by baseline renal artery disease status. Journal of Vascular Surgery 2009 50, 564-571.e3DOI: (10.1016/j.jvs.2009.03.062) Copyright © 2009 Society for Vascular Surgery Terms and Conditions
Fig 2 Model-based estimates of mean kidney length (cm) by baseline renovascular disease (RVD) status and categorical progression of RVD. Journal of Vascular Surgery 2009 50, 564-571.e3DOI: (10.1016/j.jvs.2009.03.062) Copyright © 2009 Society for Vascular Surgery Terms and Conditions
Fig 3 Predicted mean estimated glomerular filtration rate (eGFR) by unilateral renovascular disease (RVD) at baseline and bilateral peak systolic velocity (PSV) progression. Journal of Vascular Surgery 2009 50, 564-571.e3DOI: (10.1016/j.jvs.2009.03.062) Copyright © 2009 Society for Vascular Surgery Terms and Conditions
Fig 4 Predicted mean estimated glomerular filtration rate (eGFR) by patient history of diabetes and history of hyperlipidemia. Journal of Vascular Surgery 2009 50, 564-571.e3DOI: (10.1016/j.jvs.2009.03.062) Copyright © 2009 Society for Vascular Surgery Terms and Conditions
Figure A1 Estimated slopes and 95% confidence intervals (CIs) for annualized change in Peak Systolic Velocity (PSV) by patient follow-up time. “L” denotes slopes for left side; “R” denotes slopes for right side. Journal of Vascular Surgery 2009 50, 564-571.e3DOI: (10.1016/j.jvs.2009.03.062) Copyright © 2009 Society for Vascular Surgery Terms and Conditions